ArticleCancers2025

Fixed-Dose Versus Weight-Adapted Immune Checkpoint Inhibitor Therapy in Melanoma: A Retrospective Monocentric Analysis of Efficacy and Immune-Related Adverse Events.

Hans F Staender et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.